感染供者肝移植中可能供者来源感染的临床影响与结局:中国单中心回顾性研究
该单中心回顾性研究分析了2015年1月至2017年3月82例感染死亡供者及其匹配肝移植受者,发现感染受者机械通气时间和ICU停留更长、肾功能障碍及肾脏替代治疗发生率更高、住院死亡率更高。可能供者来源感染发生率为14.6%,慢加急性肝衰竭受者更易发生。
要点
- 感染供者肝移植后感染发生率高且多在术后2周内出现。
- 感染受者机械通气、ICU停留、肾功能障碍及肾脏替代治疗和住院死亡率更高。
- 可能供者来源感染发生率为14.6%,慢加急性肝衰竭受者风险更高。
核心结论
- 接受感染死亡供者肝移植的受者术后感染发生率高且感染间隔短。
- 发生可能供者来源的耐药细菌感染时,受者可能出现严重并发症和不良结局。
研究设计与样本
- 单中心观察性研究,2015年1月至2017年3月 retrospectively 收集感染死亡供者及匹配肝移植受者数据。
- 共收集211例供者信息,其中82例感染供者(脑死亡后捐献类别)及82例匹配肝移植受者纳入分析。
- 对分离微生物进行鉴定和抗生素敏感性试验,分析病原体分布和可能供者来源感染发生率。
主要发现
- 82例感染供者分离出149株病原体,革兰阳性菌占42.3%(63/149)、革兰阴性菌占46.3%(69/149)、真菌占11.4%(17/149)。
- 82例匹配肝移植受者分离出138株病原体。
- 多重耐药细菌发生率高,鲍曼不动杆菌是最受关注的菌种。
关键数值与推荐
- 可能供者来源感染发生率为14.6%。
临床怎么用
- 对感染死亡供者肝移植受者应加强术后早期感染监测,尤其是术后2周内。
- 应关注耐药细菌尤其是鲍曼不动杆菌的可能供者来源传播。
- 对慢加急性肝衰竭受者应警惕可能供者来源感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Information on possible donor-derived transmission events in China is limited. We evaluated the impacts of liver transplantation from infected deceased-donors, analyzed possible donor-derived bacterial or fungal infection events in recipients, and evaluated the etiologic agents' characteristics and cases outcomes. METHODS: A single-center observational study was performed from January 2015 to March 2017 to retrospectively collect data from deceased-donors diagnosed with infection. Clinical data were recorded for each culture-positive donor and the matched liver recipient. The microorganisms were isolated and identified, and antibiotic sensitivity testing was performed. The pathogens distribution and incidence of possible donor-derived infection (P-DDI) events were analyzed and evaluated. RESULTS: Information from 211 donors was collected. Of these, 82 donors were infected and classified as the donation after brain death category. Overall, 149 and 138 pathogens were isolated from 82 infected donors and 82 matched liver recipients, respectively. Gram-positive bacteria, Gram-negative bacteria, and fungi accounted for 42.3% (63 of 149), 46.3% (69 of 149), and 11.4% (17 of 149) of pathogens in infected donors. The incidence of multidrug-resistant bacteria was high and Acinetobacter baumannii was the most concerning species. Infections occurred within the first 2 weeks after liver transplantation with an organ from an infected donor. Compared with the noninfection recipient group, the infection recipient group experienced a longer mechanical ventilation time (P = .004) and intensive care unit stay (P = .003), a higher incidence of renal dysfunction (P = .026) and renal replacement therapy (P = .001), and higher hospital mortality (P = .015). Possible donor-derived infection was observed in 14.6% of cases. Recipients with acute-on-chronic liver failure were more prone to have P-DDI than recipients with other diseases (P = .007; odds ratio = 0.114; 95% confidence interval, .025-.529). CONCLUSIONS: When a liver recipient receives a graft from an infected deceased-donor, the postoperative incidence of infection is high and the infection interval is short. In addition, when a possible donor-derived, drug-resistant bacterial infection occurs, recipients may have serious complications and poor outcomes.
引用
- Tong L, Hu XG, Huang F, et al. Clinical Impacts and Outcomes With Possible Donor-Derived Infection in Infected Donor Liver Transplantation: A Single-Center Retrospective Study in China. J Infect Dis. 2020. PMID: 32176783. doi:10.1093/infdis/jiz591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。